159 related articles for article (PubMed ID: 15125499)
1. Propionibacterium acnes biotypes and susceptibility to minocycline and Keigai-rengyo-to.
Higaki S; Nakamura M; Morohashi M; Yamagishi T
Int J Dermatol; 2004 Feb; 43(2):103-7. PubMed ID: 15125499
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Propionibacterium acnes biotypes and Jumi-haidoku-to.
Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
J Dermatol; 2000 Oct; 27(10):635-8. PubMed ID: 11092266
[TBL] [Abstract][Full Text] [Related]
3. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
Higaki S; Kitagawa T; Kagoura M; Morohashi M; Yamagishi T
J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
[TBL] [Abstract][Full Text] [Related]
5. The correlation of Kampo formulations and their ingredients on anti-bacterial activities against Propionibacterium acnes.
Higaki S; Hasegawa Y; Morohashi M; Takayoshi Y
J Dermatol; 1995 Jan; 22(1):4-9. PubMed ID: 7897023
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I; Nishijima S; Kawabata S
Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
[TBL] [Abstract][Full Text] [Related]
7. [Biotyping of Propionibacterium acnes strains isolated from patients with acne vulgaris].
Ergin C; Kaleli I; Sahin R; Ergin S; Kaçar N
Mikrobiyol Bul; 2006; 40(1-2):15-21. PubMed ID: 16775952
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
[TBL] [Abstract][Full Text] [Related]
9. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Susceptibility, Biotypes and Phylotypes of Clinical Cutibacterium (Formerly Propionibacterium) acnes Strains Isolated from Acne Patients: An Observational Study.
Zhang N; Yuan R; Xin KZ; Lu Z; Ma Y
Dermatol Ther (Heidelb); 2019 Dec; 9(4):735-746. PubMed ID: 31538294
[TBL] [Abstract][Full Text] [Related]
11. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
[TBL] [Abstract][Full Text] [Related]
14. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes.
Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N
J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
[TBL] [Abstract][Full Text] [Related]
16. Minocycline effectively reduces acid producted by Propionibacterium granulosum.
Higaki S; Kitagawa T; Morohashi M; Yamagishi T
J Dermatol; 2002 Jan; 29(1):20-2. PubMed ID: 11837569
[TBL] [Abstract][Full Text] [Related]
17. Activity of eleven kampo formulations and eight kampo crude drugs against Propionibacterium acnes isolated from acne patients: retrospective evaluation in 1990 and 1995.
Higaki S; Nakamura M; Morohashi M; Hasegawa Y; Yamagishi T
J Dermatol; 1996 Dec; 23(12):871-5. PubMed ID: 9037918
[TBL] [Abstract][Full Text] [Related]
18. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico.
González R; Welsh O; Ocampo J; Hinojosa-Robles RM; Vera-Cabrera L; Delaney ML; Gómez M
Int J Dermatol; 2010 Sep; 49(9):1003-7. PubMed ID: 20931669
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.
Biswal I; Gaind R; Kumar N; Mohanty S; Manchanda V; Khunger N; V R; Deb M
J Infect Dev Ctries; 2016 Oct; 10(10):1140-1145. PubMed ID: 27801379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
